We recently identified a reduction in the neutrophil surface expression of common ␤ chain (␤c) of the receptor for granulocyte macrophage-colony stimulating factor (GM-CSF) in the patients with myelodysplastic syndromes (MDS). To determine the etiology of the impaired ␤c expression, ␤c mRNA from neutrophilic granulocytes of MDS patients and healthy controls was analyzed by a combination of direct reverse transcriptiase-polymerase chain reaction-based singlestrand conformational polymorphism and sequencing. Nine different ␤c transcripts were detected, but none was specific for MDS. However, one of the transcripts (␤c79) containing a 79-base intron insertion between exons V and VI was significantly increased in MDS. This 27-kd isoform consisted of the ␤c N-terminal 182 amino acids followed by a new 84-amino-acid sequence. ␤c79 was overexpressed in all MDS subtypes. No genomic mutations were detected within the intron or at the intron/exon boundaries. The isoform is predominantly located in the cytoplasm by Western blot analysis and was unable to generate high-affinity binding sites or transduce a signal for proliferation when coexpressed with the receptor for human GM-CSF ␣ chain. Our study suggests that the accumulation of the abnormal ␤c transcripts with intron V retention results in the reduction in cellsurface expression of ␤c observed in MDS. J. Leukoc. Biol. 77: 811-819; 2005.
INTRODUCTION
Granulocyte macrophage-colony stimulating factor (GM-CSF) is a multipotential hematopoietic growth factor that stimulates the proliferation, differentiation, and survival of pluripotent stem cells and myeloid, erythroid, and megakaryocytic progenitors and their progeny [1] [2] [3] [4] . It also acts as a potent stimulator of neutrophil phagocytosis [5] , chemotaxis [6] , and bactericidal activities [7, 8] . These biological activities of GM-CSF are exerted by its binding to specific receptors on the surfaces of target cells. The receptor for human GM-CSF (GMR), a member of the hematopoietin receptor superfamily [9] , is composed of an ␣ chain that binds GM-CSF by itself with low affinity [10] and a common ␤ chain (␤c) that is shared by the interleukin (IL)-3 and IL-5 receptor ␣ chains [11] . Coexpression of the ␤c with the ␣ chains converts the binding affinity generated by the ␣ chain from low to high, which initiates subsequent signal transduction [12, 13] . The cytoplasmic domain of ␤c is required for downstream signal transduction [14 -17] , while the extracellular domain of ␤c is essential for interaction with the ␣ chain-bound ligand and receptor activation [18, 19] . A number of studies about artificially created ␤c mutants have shown that a point mutation in the extracellular or transmembrane domain and a duplication or a deletion of part of the extracellular domain affect receptor functions by altering receptor stoichiometry [20 -22] . Similarly, various types of truncation in the cytoplasmic domain result in incomplete signaling or inactivation of the receptors, regardless of the composition of the receptor complex [14 -17, 23, 24] .
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders characterized by refractory cytopenia, ineffective hematopoiesis, and impaired cellular differentiation [25] [26] [27] . As a consequence of impaired differentiation, mature blood cells have various morphological and functional defects. Although nearly half of the cases with poor prognostic subtypes transform to acute leukemia, the most common causes of death in overall MDS are bacterial infections [28] that have been ascribed to impaired functions and decreased numbers of neutrophilic granulocytes [29] . Patients with MDS, show impaired responses to GM-CSF, including the chemiluminescence response and production of reactive oxygen species in response to f-Met-Leu-Phe in vitro [30 -33] .
Administration of high doses of GM-CSF to the patients induces a rapid rise in peripheral blood neutrophil counts resulting from demargination of mature neutrophils, followed by an increase in the cellularity and maturation index of bone marrow as a result of GM-CSF activities on stem cells and progenitors [34 -36] . In contrast, lower doses of GM-CSF sometimes lack a rapid neutrophil increase as a result of demargination, even in the limited number of responders [37] [38] [39] , suggesting that mature cells may be more affected in some cases. However, the molecular basis of the poor response of neutrophils to GM-CSF is unknown.
We recently found a neutrophil-specific reduction in the expression of ␤c in MDS [40] . The levels of decreased expression were correlated with the degree of hypogranular changes in neutrophils, one of the typical morphology alterations in MDS, and were associated with increased susceptibility to bacterial infections, suggesting that impaired expression of ␤c may be involved in neutrophil dysplasia in MDS.
To determine if structural abnormalities in ␤c cause its impaired cell-surface expression in MDS, sequences of entire ␤c-coding mRNAs from neutrophils of MDS patients and healthy controls were analyzed. We observed that mRNA levels of a ␤c variant, which retained intron V (␤c79), was significantly increased in MDS compared with controls and that its protein was not stably expressed on the cell surface.
MATERIALS AND METHODS

Patients
Thirteen patients with MDS were studied after obtaining informed consent and approval from the institutional Human Research Committee. According to the classification by the French-American-British (FAB) group [41] , five had refractory anemia (RA), two had RA with ringed sideroblasts (RARS), one had chronic myelomonocytic leukemia (CMMoL), three had RA with excess of blasts (RAEB), and two had RAEB in transformation (RAEBt). Patient characteristics and clinical findings are presented in Table 1 . Cases 7 and 9 had cells with defective chromosome 22, where ␤c is encoded [42] . Two separate blood samples were needed for the studies. Unfortunately, three of the nine patients who provided blood samples (see Fig. 2 ) died (#3 and #9 overt leukemia; #7 sepsis) before the second sample was collected, and Patient #5 was not available. To compensate for this loss, samples from four additional patients (#10 -13) were analyzed (see Fig. 3 ). Thirteen age-matched, healthy controls were also studied as controls.
Cell preparation
Heparinized blood was obtained by venopuncture. Following the removal of erythrocytes by 0.6% dextran (T500, Pharmacia Biotech, Uppsala, Sewden) sedimentation, polymorphonuclear leukocytes were isolated from the 70%/ 81% Percoll interface by centrifugation at 1000 g for 20 min [43] . The morphology of the cell populations was confirmed by examination of cytospins (Shandon Elliott, Runcorn, Cheshire, UK) stained with May-Grü nwald and Giemsa solution. Differential cell counts revealed that more than 95% of the cells in the fraction were neutrophilic granulocytes.
Reverse transcriptase (RT)
Total cellular RNA was extracted from polymorphonuclear leukocyte fractions using ISOGEN (Nippongene, Toyama, Japan). Using oligo-dT primers, cDNA was synthesized from the RNA by Superscript RT (Gibco-BRL, Rockville, MD). The cDNA was amplified by TaKaRa Ex Taq DNA polymerase (Takara Shuzo, Otsu, Japan) in a thermal cycler (TaKaRa Shuzo).
Polymerase chain reaction (PCR)-based singlestrand conformational polymorphism (SSCP)
Twelve kinds of PCR primer pairs, listed as 1SA-12SA in Table 2 , were labeled with IRD 800 (Aloka Co., Tokyo, Japan) and were used for PCR of reverse-transcribed RNA and intact ␤c cDNA, a control with no mutations. Figure 1 indicates the regions amplified with each primer pair in ␤c cDNA. The PCR products were denatured at 95°C for 2 min and resolved by electrophoresis in MDE gel (Hydrolink, AT Biochem, Malvern, PA) for 16 h at 650 V in a Li-Cor 4000 automated DNA sequencing system (Aloka Co.). Compared with the positions of the bands derived from intact ␤c control, differently mobilized bands were defined as aberrant fragments.
Cloning of full-length ␤c-coding region
The full-length ␤c-coding cDNA was obtained by PCR with primers 1S and 12A (Table 2 ) from the reverse-transcribed RNA of patients and controls. The products were subcloned directly into a plasmid vector, pCR4-TOPO (Invitrogen, Carlsbad, CA), using a TA cloning kit (Invitrogen) and transformed into DH5a-T1 cells. Sequencing of atypical ␤c clones and genomic DNA Five full-length, ␤c-containing plasmid clones that generated the same aberrant fragments as detected by the SSCP analysis of reverse-transcribed RNA samples were selected for sequencing. Genomic DNA was extracted using the Generation Capture Column kit (Gentra Systems Inc., Minneapolis, MN) following the manufacturer's instruction, and the 314-base fragments that include the intron V and flanking exons V and VI were amplified by 28-cycle PCR with primers 14S and 3A for subsequent sequencing. The sequences were determined by the dideoxy chain-termination method using a Thermo Sequenase cycle sequencing kit (USB, Cleveland, OH) and IRD 800-labeled primers (1S-12S for mutated clones and 3A for genomic DNA in Table 2 ) in an automated DNA sequencing system (Aloka Co.).
Semiquantitative PCR
The concentrations of reverse-transcribed mRNA templates were measuered by the band intensities of ␤-actin obtained from serially diluted templates by 25-cycle PCR [44] . The fragment 10SA within exon XIV, in which no abnormal sequence was detected by SSCP, was amplified by 30-cycle PCR as total ␤c transcripts. To obtain similar amounts of amplified 10SA fragments, patients 6, 8, and 13 needed two, four, and 2.5 times more concentrated cDNA than controls, and the same concentration of cDNA as controls was sufficient in the other patients. From the 10SA fragment-adjusted concentrations of template cDNAs, the intron V-retained transcripts were amplified using 3A and an intron-specific primer 13S that extended over the junction of the 3Ј-end of exon V and the 5Ј-end of the retained intron. The PCR products were separated by 1.5% agarose gel electrophoresis, stained with ethidium bromide, and visualized under ultraviolet light. The intensities of the bands of PCR products on the gels were measured with the National Institutes of Health (NIH; Bethesda, MD) Image program. The plasmid DNA was isolated using Mo Bio UltraClean 6 Minute Plasmid Prep Kit (Mo Bio Laboratories, Solana Beach, CA).
Cells and cell culture
The IL-3-dependent mouse hematopoietic cell line Ba/F3 was maintained in RPMI 1640 (Invitrogen) supplemented with 5% fetal calf serum (FCS) and 500 pmol/L murine IL-3 (Sigma Chemical Co., St. Louis, MO). It is noted that neither human GM-CSF nor human ␤c interacts with the murine IL-3 receptor complex. Cells expressing the GMR ␣ chain that was transfected along with the neomycin-resistance gene were cultured in the presence of 1 mg/mL G418 (Gibco-BRL). The human embryonic kidney (HEK) cell line was maintained in Dulbecco's modified Eagle's medium (Sigma Chemical Co.) supplemented with 5% FCS.
Expression constructs and transfection
The cDNAs encoding intact ␤c (a generous gift from Dr. Sumiko Watanabe, University of Tokyo, Japan) or variant were subcloned into pIREShyg2, an expression vector containing the hygromycin-resistance gene (Clontech, Palo Alto, CA). For stable transfection, 20 g of each subcloned cDNA was introduced into 4 ϫ 10 6 Ba/F3 cells by electoroporation at 270 V and 975 F by the Bio-Rad Gene Pulser (Richmond, CA). The electroporated cells were allowed to recover for 2 days in the presense of 500 pmol/L murine IL-3 and were seeded in 96-well tissue-culture plates for selection in 0.3 mg/mL hygromycin. Three independent clones, in which expression of mRNA of each introduced ␤c was confirmed by RT-PCR, were selected for a subsequent functional assay. For transient transfection, 4 g subcloned cDNA of intact or variant ␤c was incubated with 25 L Polyfect transfection reagent (Qiagen, Valenica, CA) at room temperature for 5 min, which was then added to subconfluent HEK cells in 100-mm plates. After 12-16 h, the cells were harvested for Western blot analysis.
In situ hybridization
In situ hybridization was performed as described previously [45] with a minor modification. The Ba/F3 transfectants on poly-L-lysine-coated glass slides were fixed in 4% (w/v) paraformaldehyde in PBS. The slides were dehydrated sequentially in 70%, 90%, and 100% ethanol at room temperature for 5 min each and defatted in 100% chloroform for 10 min, followed by dehydration with a series of 100%, 90%, and 70% ethanol. After treatment with 1 g/mL proteinase K at 37°C for 30 min, the cells were again fixed in 1% paraformaldehyde at room temperature for 30 min. The fixed samples were then prehybridized at 37°C for 30 min in a humid chamber with hybridization buffer containing 50% deionized formamide, 4ϫ saline-sodium citrate (SSC), 10 mM Tris (pH 7.0), 1 mM EDTA, 10 mM dithiothreitol (DTT), 1ϫ Denhardt's solution (0.02% Ficoll, polyvinylpyrrolidione, 0.02% bovine serum albumin), 0.1% sodium laurylsarkosine, and 100 mg/mL tRNA, followed by incubation for 16 h at 37°C with hybridization buffer containing 5 ng/mL digoxigeninlabeled antisense or sense probes. After washing at 42°C for 20 min with 50% formamide/2ϫ SSC and with 1ϫ SSC three times each, the cells were stained using the DIG nucleic acid detection kit (Boehringer Mannheim Biochemica, Manheim, Germany) according to the manufacturer's instructions. * "S" is forward primers, and "A" is reverse primers. † (i), Inserted sequence. Primer 13S covers nucleotides 570 -577 of ␤c and 12 nucleotides from the 5Ј-end of the inserted sequence.
Cell staining and flow cytometry analysis
Ba/F3 transfectants were incubated with rat monoclonal antibody (mAb) against human ␤c, a generous gift from Dr. Atsushi Miyajima (University of Tokyo) [46] , mouse mAb against the human GMR ␣ chain [47] 
Proliferation assay
Wild-type Ba/F3 cells, Ba/F3 cells expressing only human GMR ␣ chains, and Ba/F3 clones transfected with the GMR ␣ chain and either intact or variant ␤c were washed three times. After starvation in growth factor-free RPMI containing 5% FCS for more than 4 h, the cells were cultured in the presence of either 1 ng/mL murine IL-3 or 5 ng/mL human GM-CSF. The numbers of viable cells assessed by trypan blue exclusion were assessed every 12 h.
Binding assay
Radioiodinated human GM-CSF was purchased from Perkin Elmer Life Sciences (Boston, MA). It had a specific activity of 1.44 ϫ 10 18 cpm/mol. The binding affinities of GM-CSF to transfectants were analyzed as described previously [48] . In brief, washed cells were cultured in the absence of growth factors for 4 h, and then various concentrations of 125 I-GM-CSF were incubated with 3 ϫ 10 6 cells for 16 h at 4°C with or without a 100-fold excess of unlabeled human GM-CSF (Sigma Chemical Co.). The cells were centrifuged through a 3:2 mixture of dibutyryl phthalate (Sigma Chemical Co.):bis-phthalate oil (Sigma Chemical Co.), and radioactivities of the pellets were measured in a ␥ counter. The binding data were subjected to Scatchard analysis.
Western blot analysis
The Ba/F3 and HEK transfectants were resuspended in lysis buffer containing 1% sodium dodecyl sulfate, 10 mmol/L Tris (pH 7.6), 2 mmol/L disodium ethylenediaminetetraacetic acid, 1 mmol/L DTT, 1 mmol/L phenylmethylsulfonyl fluoride, 1 g/mL leupeptin, and 1 g/mL pepstatin. The cell lysates were mixed with an equal volume of twofold concentrated Laemmeli sample buffer containing 5% 2-mercaptoethanol, boiled for 5 min, and electrophoresed on a 12.7% polyacrylamide gel. The separated proteins were transferred onto a nitrocellulose membrane using a semi-dry Western transfer apparatus (ATTO, Amherst, NY). After blocking with 5% skim milk dissolved in Trisbuffered saline buffer (10 mmol/L Tris, pH 8.0, 150 mmol/L NaCl), the membrane was incubated for 1 h at room temperature with rabbit polyclonal antibody against human ␤c N-terminal peptide (N-20, Santa Cruz Biotechnology, CA) followed by incubation for 1 h at room temperature with horseradish peroxidase-conjugated donkey anti-rabbit IgG (Amersham, Arlington Heights, IL). Signals were detected by enhanced chemiluminescence (Amersham).
Statistical analysis
The Mann-Whitney test was used to compare MDS patients and controls with respect to the ratios of the PCR band intensities derived from variant ␤c to those from total ␤c.
RESULTS
␤c transcripts detected by direct RT-PCR-SSCP
To detect atypical transcripts of ␤c, PCR-SSCP analysis was carried out on reverse-transcribed mRNA prepared from nine MDS patients (Nos. 1-9 in Table 1 ) and seven healthy controls using 12 primer pairs shown in Figure 1 . Compared with the electrophoretic patterns derived from intact ␤c cDNA control, at least nine abnormally mobilized bands were detected in 1SA, 2SA, 6SA, 7SA, and 9SA fragments as indicated by A-I in Figure 2 . These abnormal bands always coexisted with predominant, intact fragments in each patient. None of them was specific to MDS, as they were found in patients and controls. The only difference between patients and controls was the intensities of band "B," amplified with a sense primer 2S in exon IV and an antisense primer 2A in exon VI. Band "B" was obviously stronger in MDS than in controls, suggesting that the corresponding aberration was increased in MDS patients compared with healthy individuals. No abnormal transcripts were found in the regions amplified by 3SA, 4SA, 5SA, 8SA, 10SA, 11SA, and 12SA primer pairs (data not shown).
Sequences of the abnormal transcripts
The ␤c cDNA clones that generated the same SSCP aberrations as A-I in Figure 2 were sequenced. As presented in Table 3 , the aberration that generated band "B" was an insertion of 79 bases at nucleotide position 578, the junction of exons V and VI. The analyses of three independent clones confirmed that the inserted sequence was completely identical to that of the intron between exons V and VI registered in the database. Sequencing of genomic DNA also revealed that the insertion was intron V in ␤c and that neither patients nor controls had mutations in the intron and exon/intron boundaries (data not shown). The insertion caused a frameshift and generated a premature stop codon in the extracellular domain, predicting a truncated ␤c isoform composed of conserved N-terminal 182 Fig. 2 . Aberrant ␤c transcripts detected by direct RT-PCR-SSCP. cDNA was synthesized from RNA extracted from neutrophils of seven controls and nine MDS patients using oligo-dT primers and was followed by 32 PCR amplification cycles with 12 kinds of IRD 800-labeled primer pairs, 1SA-12SA listed in Table 2 . As controls with correct sequences, intact ␤c cDNA was amplified by 20 PCR cycles with the same primers. The PCR products were resolved on the MDE gels. The patient numbers correspond to those in Table 1 . The arrows on the right indicate nine abnormally mobilized bands that were subsequently sequenced. 
Comparison of the incidence of the intron Vretained ␤c variants (␤c79) between MDS and controls by semiquantitative RT-PCR
The ratios of the intron V-retained variants (␤c79) to total ␤c transcripts were compared between MDS patients and controls by RT-PCR. The PCR1 specifically amplified the ␤c79 as the 222-bp fragments, and 266-bp fragments were obtained by PCR2 regardless of intron V retention (Fig. 3a) . Figure 3b shows that more PCR1 fragment was obtained in each MDS patient compared with healthy controls, whereas similar amounts of PCR2 fragments were amplified with no significant difference in the band intensities between MDS patients and controls (Pϭ0.3329). The measurement of band intensities derived from the ␤c79 cDNA indicated that difference in PCR efficiency between PCR1 and PCR2 resulted in a ratio of 1.808 when 100% of the expressed ␤c transcripts retained the intron (Fig. 3c) . Statistically, MDS patients showed a significantly higher ratio (0.795Ϯ0.188) than healthy individuals (0.112Ϯ0.076; PϽ0.001; Fig. 3c ). The ratios in the patients with RA or RARS (0.863Ϯ0.187) were higher than those in RAEB/RAEBt (0.659Ϯ0.113; PϽ0.05), which were still significantly higher than controls (PϽ0.01). This experiment was performed twice, and similar results were obtained.
␤c expression in transfected Ba/F3
To examine the effects of intron retention on receptor functions, the cDNA of intact ␤c or ␤c79 was introduced into a murine IL-3-dependent cell line, Ba/F3, along with the human GMR ␣ chain, and the expression of introduced ␤c mRNA in the isolated clones was confirmed by RT-PCR (Fig. 4a) . The intron-containing 222-bp fragments were detected in Ba/F3 clones transfected with ␤c79 but not with intact ␤c [Fig. 4a , (1)]. The PCR with primer 2S and 3A, which sandwiched the retained intron, generated 387-bp and 466-bp fragments from the intact ␤c-and ␤c79-transfected clones, respectively [ Fig.  4a (2) ]. These data confirmed that the clones tested expressed the introduced ␤c, at least at the mRNA level. In situ hybridization using an antisense probe complementary to the sequence within the intron V showed that 100% of the cells in each ␤c79-transfected clone expressed intron V-containing RNA, and the cells did not react with a sense probe (Fig. 4b) . The clones with intact ␤c did not react with either probe. Western blot analysis indicates that the transfected ␤c and ␤c79 were detected as the expected molecular weights in Ba/F3 (130 kd and 27 kd, respectively; Fig. 4c ).
Effects of the intron V retention on receptor function
To assess the function of the isoform as a signal transducer, proliferation of transfectants in response to human GM-CSF was examined. All transfectants proliferated in the presence of murine IL-3, as did the wild-type and the GMR ␣ chainexpressing Ba/F3 (Fig. 5a) . Although the cells expressing intact ␤c with the ␣ chain proliferated in response to human GM-CSF, all three clones with ␤c79 and GMR ␣ chain (mG7, mE10, mF10) failed to grow and decreased in numbers, as did wild-type Ba/F3 and Ba/F3 expressing only the GMR ␣ chain (Fig. 5b) .
As signal transduction via GMR requires association of ␣ chain with ␤c, resulting in high-affinity binding of GM-CSF, it was assessed if the isoform can form a high-affinity complex with the ␣ chain. Although coexpression of intact ␤c with the GMR ␣ chain converted the low-affinity binding by the GMR ␣ chain (3.3 nM) to high-affinity binding (39.8 pM), the isoform neither generated high-affinity sites nor interfered with the binding of the ligand to the ␣ chain ( Table 4) . 
Localization of the translated proteins
To determine if ␤c79 is expressed at the cell surface, ␤c79-transfected Ba/F3 cells were incubated with antibodies against the extracellular domains of human ␤c or GMR ␣ chain and analyzed by flow cytometry. As shown in Figure 6a , ␤c79 expression was not detected, and intact ␤c was recognized. Similar amounts of the GMR ␣ chain were present in both transfectants. The localization of transfected ␤c proteins was further examined by Western blot analysis of HEK cells transiently transfected with ␤c and ␤c79. The blot, using whole cell lysates, confirmed that the ␤c79 was present as a 27-kd protein (Fig. 6b) . The 130-kd intact ␤c was observed in both membrane and cytosol fractions in similar amounts as shown in Figure 6c . However, the 27-kd truncated isoform, which was present in the cytosol fraction, was almost absent in the membrane fraction (Fig. 6d ).
DISCUSSION
Our previous data, showing that reduced ␤c expression could result in neutrophil dysplasia [40] , prompted us to investigate its etiology. We first examined whether structural abnormalities in ␤c caused the reduction in GMR surface expression.
RT-PCR-SSCP showed that one transcript was increased in MDS patients compared with healthy controls. This transcript was found to contain an intron-identical 79-base insertion between exons V and VI. Contamination of genomic DNA was excluded for the following reasons. When RNA samples were subjected to RT-PCR-SSCP, small introns, such as a 566-base intron VI and 161-base intron VII sandwiched by a primer pair 4SA, were not detected by 1.5% agarose gel or acrylamide gel electrophoresis. In addition, the sequenced clones, which had full-length ␤c mRNA sequence using primers 1S and 12A, did not contain other introns (data not shown). These suggests that the intron V was transcribed to mRNA and was possibly exempted from splicing in neutrophils. Thus, the transcripts with the retained intron V appear to be mis-spliced variants. The elevated level of ␤c79 compared with total ␤c in MDS was confirmed by RT-PCR. Unfortunately, limited amounts of neutrophil RNA isolated from cytopenic patients precluded direct quantification such as Northern blotting [44, 49] . The ␤c79 was specifically amplified using an intron V-specific sense primer. To amplify total ␤c transcripts with or without intron V retention, we used the primer pair 10SA (Fig. 3a) that located within exon XIV, where splicing is evitable, and no aberrations were detected by SSCP. As described in Materials and Methods, all three patients with RAEB needed more concentrated cDNA template to obtain the same levels of 10SA fragments as controls, suggesting that total ␤c transcription levels were reduced in these patients. In RA/RARS, the total ␤c transcription levels were considered to be similar to those of controls, as similar levels of 10SA fragments were generated from the same concentration of cDNA as controls. Although patients with RAEB may have smaller ratios, more cases need to be studied to determine if there are significant differences among disease subtypes. The increased amount of ␤c79 in all patient samples tested suggests that its accumulation is a universal feature of MDS. This is an important finding, as the other molecular and genomic abnormalities reported in MDS are not as consistent [50] .
The intron V retention in ␤c79 abrogated the receptor activity by reducing cell-surface GMR expression. Previous studies have shown that the ␤c lacking its cytoplasmic domain was incapable of transducing a signal but not interacting with the ␣ chain [12] [13] [14] [15] [16] [17] ; we therefore tested the possibility of functional interactions of the isoform with the ␣ chain by binding assay. The results of flow cytometry analysis of Ba/F3 transfectants showed that ␤c79 was not expressed on the cell surface. To confirm the localization of translated ␤c79, we used Table 1 . The ␤c79 and intact ␤c cDNAs subcloned into vectors were subjected to the same analysis as substitutes for samples in which 100% and 0% of ␤c had the insertion, respectively. (c) Ratios of the band intensities of ␤c79 to total ␤c. The NIH Image program measured the PCR band intensities of each patient, and the ratios of PCR1 to PCR2 were compared between MDS patients and controls. When 100% of ␤c was ␤c79, the ratio was 1.808 because of higher efficiency of PCR1 than PCR2, as shown by the result with ␤c79 cDNA. *, Significant difference; P Ͻ 0.001. transient HEK transfectants that were thought to express introduced genes more efficiently. Western blot analysis of HEK cells also demonstrated that the truncated isoform was not expressed on the cell surface. The elevated incidence of the variants without compensatory increase in total ␤c transcripts in MDS patients may result in reduction of intact ␤c and reduced cell-surface GMR ␤c expression.
The identification and characterization of ␤c79 are novel findings. Analysis of mRNA and genomic DNA encoding the ␤c extracellular domain in patients with acute leukemia detected only four kinds of point mutations with no differences in their frequencies between patients and controls [51] . We detected one of them as "D" (Fig. 2) . Another study detected a deletion of the entire exon XIII corresponding to our "H" (Fig.  2) but not intron V-retention in blasts from acute myeloid leukemia patients [24] . The intron V retention in ␤c mRNA is therefore rare in de novo acute leukemia but appears to be characteristic of MDS. Further studies will determine whether elevated ␤c79 is a potential diagnostic marker for patients with MDS.
Aberrant splice products have been found in leukemia, including the skipping of exons in deoxycytidine kinase [52] and SMAD5 [53] , in addition to the ␤c without exon XIII [24] , and an intron retention in protein tyrosine phosphatase, nonreceptor type 6 (PTPN6) [54] . Expression of these variants was restricted in leukemic blasts and CD34 ϩ stem cells [24] or decreased during culturing in the presence of differentiationstimulating cytokines [53] , suggesting that the expression of alternative splice variants is differentially regulated during hematopoiesis. Our results may be characterized by the following: First, the abnormal ␤c is detected in the terminally differentiated neutrophils. Second, the genomic mutations that typically cause abnormal splicing were not found in the patients with ␤c79 overexpression, whereas the intron retention in PTPN6 occurs from a point mutation within the intron [54] .
The biological significance of increased ␤c79 in neutrophils is not fully understood at this time. It is to be studied if the variant has dominant-negative effects on intact ␤c. It would be RT-PCR. cDNA was prepared from total cellular RNA extracted from wild-type Ba/F3, human GMR ␣ chain-expressing Ba/F3, each of three Ba/F3 clones transfected with GMR ␣ chain ϩ intact ␤c (CE3, EE4, CF10), and GMR ␣ chain ϩ ␤c79 (mG7, mE10, and mF19) using oligo-dT primers for subsequent PCR. ␤c79 and intact ␤c cDNAs in expression vectors, which were used for the transfections, were also subjected PCR as controls. (1) interesting to determine whether the reduction in functional ␤c affects IL-3 receptor activity, which can be detected on GM-CSF-stimulated neutrophils.
In conclusion, we demonstrate that increased ␤c79 expression results in the reduced GMR expression and the reduced GM-CSF receptor activity observed in neutrophils of MDS patients. 
